Endophthalmitis: A review of current evaluation and management

Retina

Volumn 27, Issue 6, 2007, Pages 662-680

  Lemley, Craig A ^a   Han, Dennis P ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b EYE INSTITUTE   (United States)

Author keywords

Corticosteroids; Endogenous endophthalmitis; Endophthalmitis; Endophthalmitis Vitrectomy Study; Intravitreal antibiotics; Intravitreal injection; Pars plana vitrectomy; Postoperative endophthalmitis; Trabeculectomy; Trauma; Vitreous biopsy; Vitreous tap

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; CEFAMANDOLE; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; DEXAMETHASONE; FLUCONAZOLE; FLUOROURACIL; GANCICLOVIR; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; METICILLIN; MICONAZOLE; MITOMYCIN C; MOXIFLOXACIN; PREDNISONE; QUINOLONE DERIVATIVE; STEROID; TOBRAMYCIN; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE;

ANALYTIC METHOD; BEHCET DISEASE; CATARACT EXTRACTION; CILIARY DISK; CLINICAL TRIAL; CORNEA OPACITY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; ENDOPHTHALMITIS; EYE DISEASE; HUMAN; HYPOPYON; KERATITIS; LOW DRUG DOSE; MACULAR INFARCTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PROPIONIBACTERIUM; RETINA DISEASE; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TOXI ANTERIOR SEGMENT SYNDROME; VIRULENCE; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS BIOPSY;

ENDOPHTHALMITIS; HUMANS;

EID: 34447305200     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3180323f96     Document Type: Review

References (168)

1. Packer AJ, Weingeist TA, Abrams GW. Retinal periphlebitis as an early sign of bacterial endophthalmitis. Am J Ophthalmol 1983;96:66-71.
2. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-1496.
3. Verbraeken H. Treatment of postoperative endophthalmitis. Ophthalmologica 1995;209:165-171.
4. Javitt JC, Street DA, Tielsch JM, et al. National outcomes of cataract extraction; retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology 1994;101:100-105.
5. Norregaard JC, Thoning B, Bernth-Petersen P, et al. Risk of endophthalmitis after cataract surgery: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol 1997;81:102-106.
6. Somani S, Grinbaum A, Slomovic AR. Postoperative endophthalmitis: incidence, predisposing surgery, clinical course and outcome. Can J Ophthalmol 1997;32303-32310.
7. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative survey; a 10-year review of incidence and outcomes. Ophthalmology 1998;105:1004-1010.
8. Morlet N, Gatus B, Coroneo M. Patterns of peri-operative prophylaxis for cataract surgery: a survey of Australian ophthalmologists. Aust NZ J Ophthalmol 1998;26:5-12.
9. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 2005;123:613-620.
10. Cooper BA, Holekamp NM, Bohigian G, Thompson PA. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol 2003;136:300-305.
11. Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial endophthalmitis after small-incision cataract surgery. Effect of incision placement and intraocular lens type. J Cataract Refract Surg 2003;29:20-26.
12. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998;105:1004-1010.
13. Eifrig CW, Flynn HW Jr, Scott IU, Newton J. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers 2002;33:373-378.
14. Taban M, Behrens A, Newcomb RL, et al. Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol 2005;123:605-609.
15. Busbee BG, Recchia FM, Kaiser R, et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology 2004;111:1495-1503.
16. Al-Torbak AA, Al-Shahwan S, Al-Jadaan I, et al. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol 2005;89:454-458.
17. Recchia FM, Baumal CR, Sivalingam A, et al. Endophthalmitis after pediatric strabismus surgery. Arch Ophthalmol 2000;118:939-944.
18. Oshima Y, Ohji M, Inoue Y, et al. Methicillin-resistant Staphylococcus aureus infections after scleral buckling procedures for retinal detachments associated with atopic dermatitis. Ophthalmology 1999;106:142-147.
19. Farrell PL, Smith RE. Bacterial corneoscleritis complicating pterygium excision. Am J Ophthalmol 1989;107:515-517.
20. Culbert RB, Devenyi RG. Bacterial endophthalmitis after suture removal. J Cataract Refract Surg 1999;25:725-727.
21. Mamalis N, Edelhauser HF, Dawson DG, et al. Toxic anterior segment syndrome. J Cataract Refract Surg 2006;32:324-333.
22. Werner L, Sher JH, Taylor JR, et al. Toxic anterior segment syndrome and possible association with ointment in the anterior chamber following cataract surgery. J Cataract Refract Surg 2006;32:227-235.
23. McCray E, Rampell N, Solomon SL, et al. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J Clin Microbiol 1986;24:625-628.
24. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study [erratum in: Am J Ophthalmol 1996;122:920]. Am J Ophthalmol 1996;122:1-17.
25. Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639-649.
26. Samad A, Solomon LD, Miller MA, Mendelson J. Anterior chamber contamination after uncomplicated phacoemulsification and intraocular lens implantation. Am J Ophthalmol 1995;120:143-150.
27. Leong JK, Shah R, McCluskey PJ, et al. Bacterial contamination of the anterior chamber during phacoemulsification cataract surgery. J Cataract Refract Surg 2002;28:826-833.
28. Gimbel HV, Sun R, DeBroff BM, Yang HM. Anterior chamber fluid cultures following phacoemulsification and posterior chamber lens implantation. Ophthalmic Surg Lasers 1996;27:121-126.
29. Ariyasu RG, Nakamura T, Trousdale MD, Smith RE. Intraoperative bacterial contamination of the aqueous humor. Ophthalmic Surg 1993;24:367-373.
30. Manners TD, Chitkara DK, Marsh PJ, Stoddart MG. Anterior chamber aspirate cultures in small incision cataract surgery. Br J Ophthalmol 1995;79:878-880.
31. Tervo T, Ljungberg P, Kautiainen T, et al. Prospective evaluation of external ocular microbial growth and aqueous humor contamination during cataract surgery. J Cataract Refract Surg 1999;25:65-71.
32. Sherwood DR, Rich WJ, Jacob JS, Hart RJ, Fairchild YL. Bacterial contamination of intraocular and extraocular fluids during extracapsular cataract extraction. Eye 1989;3:308-312.
33. Dickey JB, Thompson KD, Jay WM. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am J Ophthalmol 1991;112:278-282.
34. Bauman WC, D'Amico DJ. Surgical techniques in diagnosis and management of suspected endophthalmitis. Int Ophthalmol Clin 1992;32:113-128.
35. Meredith TA, Trabelsi A, Miller MJ, et al. Spontaneous sterilization in experimental Staphylococcus epidermidis endophthalmitis. Invest Ophthalmol Vis Sci 1990;31:181-186.
36. Barza M, Pavan PR, Doft BH, et al. Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1997;115:1142-1150.
37. Han DP, Wisniewski SR, Kelsey SF, et al. Microbiologic yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. Retina 1999;19:98-102.
38. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis. Review of 36 cases. Ophthalmology 1982;89:921-929.
39. Shaarawy A, Meredith TA, Kincaid M, et al. Intraocular injection of ceftazidime. Effects of inflammation and surgery. Retina 1995;15:433-438.
40. Aguilar HE, Meredith TA, el-Massry A, et al. Vancomycin levels after intravitreal injection. Effects of inflammation and surgery. Retina 1995;15:428-432.
41. Kuhn F, Gini G. Ten years after. Are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol 2005;243:1197-1199.
42. Doft BH, Kelsey SF, Wisniewski SR. Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study. Ophthalmology 1998;105:707-716.
43. Recchia FM, Busbee BG, Pearlman RB, et al. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol 2005;123:341-346.
44. Anand AR, Therese KL, Madhavan HN. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Ind J Ophthalmol 2000;48:123-128.
45. Miller D, Flynn PM, Scott IU, et al. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 2006;124:479-483.
46. Gao H, Pennesi ME, Qiao X, et al. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models. Invest Ophthalmol Vis Sci 2006;47:1606-1611.
47. Kazi AA, Jermak CM, Peyman GA, Aydin E, Riazi-Esfahani M. Intravitreal toxicity of levofloxacin and gatifloxacin. Ophthalmic Surg Lasers Imaging 2006;37:224-229.
48. Esmaeli B, Holz ER, Ahmadi MA, Krathen RA, Raad II. Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection. Retina 2003;23:118-119.
49. Bains HS, Weinberg DV, Feder RS, Noskin GA. Postoperative vancomycin-resistant enterococcus faecium endophthalmitis. Arch Ophthalmol 2007 (in press).
50. Buerk M, Fiscella R, Johnson S, Edward D. Intravitreal toxicity of linezolid in rabbits. Invest Ophthalmol Vis Sci 2004;45: E-Abstract 4902.
51. Campochiaro PA, Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Study Group. Arch Ophthalmol 1994;112:48-53.
52. Cannon JP, Fiscella R, Pattharachayakul S, et al. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest Ophthalmol Vis Sci 2003;44:2112-2117.
53. Souri EN, Green WR. Intravitreal amphotericin B toxicity. Am J Ophthalmol 1974;78:77-81.
54. Campochiaro PA, Green WR. Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol 1992;110:1625-1629.
55. Jay WM, Fishman P, Aziz M, Shockley RK. Intravitreal ceftazidime in a rabbit model: dose- and time-dependent toxicity and pharmacokinetic analysis. J Ocul Pharmacol 1987;3:257-262.
56. Homer P, Peyman GA, Koziol J, Sanders D. Intravitreal injection of vancomycin in experimental staphylococcal endophthalmitis. Acta Ophthalmol 1975;53:311-320.
57. Pflugfelder SC, Hernandez E, Fliesler SJ, Alvarez J, Pflugfelder ME, Forster RK. Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. Arch Ophthalmol 1987;105:831-837.
58. Gao H, Pennesi ME, Shah K, et al. Intravitreal voriconazole: an electroretinographic and histopathologic study. Arch Ophthalmol 2004;122:1687-1692.
59. Engelbert M, Mino de Kaspar H, Thiel M, et al. Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis. Graefes Arch Clin Exp Ophthalmol 2004;242:313-320.
60. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol 2003;121:345-350.
61. Hariprasad SM, Shah GK, Mieler WF, et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol 2006;124:178-182.
62. Barza M, Doft B, Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Ophthalmol 1993;111:492-494.
63. Iyer MN, Han DP, Yun HJ, et al. Subconjunctival antibiotics for acute postcataract extraction endophthalmitis: is it necessary? Am J Ophthalmol 2004;137:1120-1121.
64. Smiddy WE, Smiddy RJ, Ba'Arath B, et al. Subconjunctival antibiotics in the treatment of endophthalmitis managed without vitrectomy. Retina 2005;25:751-758.
65. Solomon R, Donnenfeld ED, Perry HD, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005;112:466-469.
66. Costello P, Bakri SJ, Beer PM, et al. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina 2006;26:191-195.
67. Irvine WD, Flynn HW Jr, Miller D, Pflugfelder SC. Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol 1992;110:1450-1454.
68. Mao LK, Flynn HW Jr, Miller D, Pflugfelder SC. Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol 1993;116:584-589.
69. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol 1999;83:1050-1055.
70. Gan IM, Ugahary LC, van Dissel JT, et al. Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Graefes Arch Clin Exp Ophthalmol 2005;243:1200-1205.
71. Shah GK, Stein JD, Sharma S, et al. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000;107:486-489.
72. Falk NS, Beer PM, Peters GB 3rd. Role of intravitreal triamcinolone acetonide in the treatment of postoperative endophthalmitis. Retina 2006;26:545-548.
73. Koul S, Philipson BT, Philipson A. Visual outcome of endophthalmitis in Sweden. Acta Ophthalmol (Copenh) 1989;67:504-509.
74. Mandell BA, Meredith TA, Aguilar E, et al. Effects of inflammation and surgery on amikacin levels in the vitreous cavity. Am J Ophthalmol 1993;115:770-774.
75. Barza M, Lynch E, Baum JL. Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits. Arch Ophthalmol 1993;111:121-125.
76. Oum BS, D'Amico DJ, Kwak HW, Wong KW. Intravitreal antibiotic therapy with vancomycin and aminoglycoside: examination of the retinal toxicity of repetitive injections after vitreous and lens surgery. Graefes Arch Clin Exp Ophthalmol 1992;230:56-61.
77. The Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996;122:830-846.
78. Samson CM, Foster CS. Chronic postoperative endophthalmitis. Int Ophthalmol Clin 2000;40:57-67.
79. Fox GM, Joondeph BC, Flynn HW Jr, Pflugfelder SC, Roussel TJ. Delayed-onset pseudophakic endophthalmitis. Am J Ophthalmol 1991;111:163-173.
80. Roussel TJ, Olson ER, Rice T, et al. Chronic postoperative endophthalmitis associated with Actinomyces species. Arch Ophthalmol 1991;109:60-62.
81. Zimmerman PL, Mamalis N, Alder JB, et al. Chronic Nocardia asteroides endophthalmitis after extracapsular cataract extraction. Arch Ophthalmol 1993;111:837-840.
82. Ficker L, Meredith TA, Wilson LA, Kaplan HJ, Kozarsky AM. Chronic bacterial endophthalmitis. Am J Ophthalmol 1987;103:745-748.
83. Pflugfelder SC, Flynn HW Jr, Zwickey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology 1988;95:19-30.
84. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol 1998;43:193-224.
85. Zambrano W, Flynn HW Jr, Pflugfelder SC, et al. Management options for Propionibacterium acnes endophthalmitis. Ophthalmology 1989;96:1100-1105.
86. Chien AM, Raber IM, Fischer DH, Eagle RC Jr, Naidoff MA. Propionibacterium acnes endophthalmitis after intracapsular cataract extraction. Ophthalmology 1992;99:487-490.
87. Aldave AJ, Stein JD, Deramo VA, et al. Treatment strategies for postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999;106:2395-2401.
88. Hykin PG, Tobal K, McIntyre G, et al. The diagnosis of delayed post-operative endophthalmitis by polymerase chain reaction of bacterial DNA in vitreous samples. J Med Microbiol 1994;40:408-415.
89. Flynn W Jr, Scott IU, Brod RD, Han DP. Current management of endophthalmitis. Int Ophthalmol Clin 2004;44:115-137.
90. Ciulla TA. Update on acute and chronic endophthalmitis. Ophthalmology 1999;106:2237-2238.
91. Tyrrell KL, Citron DM, Warren YA, et al. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes. Antimicrob Agents Chemother 2006;50:2728-2731.
92. Oprica C, Nord CE. ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 2005;11:204-213.
93. Shames R, Satti F, Vellozzi EM, Smith MA. Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem and cefepime. J Clin Microbiol 2006 44:4227-4228. [Epub 2006 Sept 13]
94. Clark WL, Kaiser PK, Flynn HW Jr, et al. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999;106:1665-1670.
95. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 2002;109:985-991.
96. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103:650-656.
97. Hattenhauer JM, Lipsich MP. Late endophthalmitis after filtering surgery. Am J Ophthalmol 1971;72:1097-1101.
98. Ciulla TA, Baker AS. Endophthalmitis following glaucoma filtering surgery. Int Ophthalmol Clin 1996;36:87-96.
99. Greenfield DS, Suner IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996;114:943-949.
100. Borisuth NS, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol 1999;10:112-116.
101. Parrish R, Minckler D. "Late endophthalmitis"-filtering surgery time bomb? Ophthalmology 1996;103:1167-1168.
102. Wolner B, Liebmann JM, Sassani JW, et al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology 1991;98:1053-1060.
103. Ciulla TA, Beck AD, Topping TM, Baker AS. Blebitis, early endophthalmitis, and late endophthalmitis after glaucoma-filtering surgery. Ophthalmology 1997;104:986-995.
104. Mandelbaum S, Forster RK. Endophthalmitis associated with filtering blebs. Int Ophthalmol Clin 1987;27:107-111.
105. Kangas TA, Greenfield DS, Flynn HW Jr, Parrish RK 2nd, Palmberg P. Delayed-onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology 1997;104:746-752.
106. Krzystolik MG, Ciulla TA, Topping TM, Baker AS. Exogenous Aspergillus niger endophthalmitis in a patient with a filtering bleb. Retina 1997;17:461-462.
107. Brown RH, Yang LH, Walker SD, et al. Treatment of bleb infection after glaucoma surgery. Arch Ophthalmol 1994;112:57-61.
108. Busbee BG. Update on treatment strategies for bleb-associated endophthalmitis. Curr Opin Ophthalmol 2005;16:170-174.
109. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463-466.
110. Phillips WB 2nd, Wong TP, Bergren RL, Friedberg MA, Benson WE. Late onset endophthalmitis associated with filtering blebs. Ophthalmic Surg 1994;25:88-91.
111. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24:S3-19.
112. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina 2004;24:676-698.
113. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-796.
114. Nelson ML, Tennant MT, Sivalingam A, et al. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003;23:686-691.
115. Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology 2006;113:642.e1-e4. [Epub 2006 Feb 14]
116. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816.
117. Cantrill HL, Henry K, Melroe NH, et al. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthalmology 1989;96:367-374.
118. Roth DB, Chieh J, Spirn MJ, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-1282.
119. Moshfeghi DM, Kaiser PK, Bakri SJ, et al. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging 2005;36:24-29.
120. Bucher RS, Hall E, Reed DM, et al. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Arch Ophthalmol 2005;123:649-653.
121. Azad R, Ravi K, Talwar D, et al. Pars plana vitrectomy with or without silicone oil endotamponade in post-traumatic endophthalmitis. Graefes Arch Clin Exp Ophthalmol 2003;241:478-483.
122. Verbraeken H, Rysselaere M. Post-traumatic endophthalmitis. Eur J Ophthalmol 1994;4:1-5.
123. Essex RW, Yi Q, Charles PG, Allen PJ. Post-traumatic endophthalmitis. Ophthalmology 2004;111:2015-2022.
124. Ariyasu RG, Kumar S, LaBree LD, Wagner DG, Smith RE. Microorganisms cultured from the anterior chamber of ruptured globes at the time of repair. Am J Ophthalmol 1995;119:181-188.
125. Rubsamen PE, Cousins SW, Martinez JA. Impact of cultures on management decisions following surgical repair of penetrating ocular trauma. Ophthalmic Surg Lasers 1997;28:43-49.
126. Thompson WS, Rubsamen PE, Flynn HW Jr, Schiffman J, Cousins SW. Endophthalmitis after penetrating trauma. Risk factors and visual acuity outcomes. Ophthalmology 1995;102:1696-1701.
127. Brinton GS, Topping TM, Hyndiuk RA, et al. Posttraumatic endophthalmitis. Arch Ophthalmol 1984;102:547-550.
128. Boldt HC, Pulido JS, Blodi CF, Folk JC, Weingeist TA. Rural endophthalmitis. Ophthalmology 1989;96:1722-1726.
129. Thompson JT, Parver LM, Enger CL, Mieler WF, Liggett PE. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. National Eye Trauma System. Ophthalmology 1993;100:1468-1474.
130. Jonas JB, Knorr HL, Budde WM. Prognostic factors in ocular injuries caused by intraocular or retrobulbar foreign bodies. Ophthalmology 2000;107:823-828.
131. Mieler WF, Ellis MK, William DF, Han DP. Retained intraocular foreign bodies and endophthalmitis. Ophthalmology 1990;97:1532-1538.
132. Seal DV, Kirkness CM. Criteria for intravitreal antibiotics during surgical removal of intraocular foreign bodies. Eye 1992;6:465-468.
133. Soheilian M, Rafati N, Peyman GA. Prophylaxis of acute posttraumatic bacterial endophthalmitis with or without combined intraocular antibiotics: a prospective, double-masked randomized pilot study. Int Ophthalmol 2001;24:323-330.
134. Reynolds DS, Flynn HW Jr. Endophthalmitis after penetrating ocular trauma. Curr Opin Ophthalmol 1997;8:32-38.
135. Mittra RA, Mieler WF. Controversies in the management of open-globe injuries involving the posterior segment. Surv Ophthalmol 1999;44:215-225.
136. Sternberg P Jr, Martin DF. Management of endophthalmitis in the post-endophthalmitis vitrectomy study era. Arch Ophthalmol 2001;119:754-755.
137. Affeldt JC, Flynn HW Jr, Forster RK, et al. Microbial endophthalmitis resulting from ocular trauma. Ophthalmology 1987;94:407-413.
138. Alfaro DV, Roth D, Liggett PEP. Posttraumatic endophthalmitis. Causative organisms, treatment, and prevention. Retina 1994;14:206-211.
139. Foster RE, Martinez JA, Murray TG, et al. Useful visual outcomes after treatment of Bacillus cereus endophthalmitis. Ophthalmology 1996;103:390-397.
140. Mieler WF, Glazer LC, Bennett SR, Han DP. Favorable outcome of traumatic endophthalmitis with associated retinal breaks or detachment. Can J Ophthalmol 1992;27:348-352.
141. Narang S, Gupta V, Gupta A, et al. Role of prophylactic intravitreal antibiotics in open globe injuries. Ind J Ophthalmol 2003;51:39-44.
142. Alfaro DV 3rd, Hudson SJ, Kasowski EJ, et al. Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem. Retina 1997;17:139-145.
143. Soheilian M, Rafati N. Posttraumatic endophthalmitis. Ophthalmology 2005;112:1845-1846.
144. Meredith TA. Posttraumatic endophthalmitis. Arch Ophthalmol 1999;117:520-521.
145. Peyman GA, Daun M. Prophylaxis of endophthalmitis. Ophthalmic Surg 1994;25:671-674.
146. Shrader SK, Band JD, Lauter CB, Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990;162:115-120.
147. Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003;48:403-423.
148. Chee SP, Jap A. Endogenous endophthalmitis. Curr Opin Ophthalmol 2001;12:464-470.
149. Okada AA, Johnson RP, Liles WC, D'Amico DJ, Baker AS. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 1994;101:832-838.
150. Wong JS, Chan TK, Lee HM, Chee SP. Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology 2000;107:1483-1491.
151. Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol 1986;31:81-101.
152. Nakayama F, Soloway RD, Nakama T, et al. Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci 1986;31:21-26.
153. Essman TF, Flynn HW Jr, Smiddy WE, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1997;28:185-194.
154. O'Day DM, Head WS, Robinson RD, Stern WH, Freeman JM. Intraocular penetration of systemically administered antifungal agents. Curr Eye Res 1985;4:131-134.
155. O'Day DM, Foulds G, Williams TE, et al. Ocular uptake of fluconazole following oral administration. Arch Ophthalmol 1990;108:1006-1008.
156. Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 2004;122:42-47.
157. Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004;137:820-825.
158. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 2001;150:101-115.
159. Scott IU, Cruz-Villegas V, Flynn HW Jr, Miller D. Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. Am J Ophthalmol 2004;137:583-585.
160. Garbino J, Ondrusova A, Baglivo E, et al. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 2002;34:701-703.
161. Reis A, Sundmacher R, Tintelnot K, et al. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 2000;84:932-933.
162. Figueroa MS, Fortun J, Clement A, De Arevalo BF. Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole. Retina 2004;24:319-320.
163. Zayit-Soudry S, Neudorfer M, Barak A, et al. Endogenous Phialemonium curvatum endophthalmitis. Am J Ophthalmol 2005;140:755-757.
164. Hua G, Pennesi M, Shah K, et al. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc 2003;101:183-189.
165. Breit SM, Hariprasad SM, Mieler WF, et al. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 2005;139:135-140.
166. Kramer M, Kramer MR, Blau H. Endophthalmitis after penetrating trauma. Risk factors and visual acuity outcomes. Ophthalmology 1995;102:1696-1701.
167. Schulman JA, Peyman GA. Intravitreal corticosteroids as an adjunct in the treatment of bacterial and fungal endophthalmitis. A review. Retina 1992;12:336-340.
168. Coats ML, Peyman GA. Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis. Retina 1992;12:46-51.